共 25 条
- [21] Decreased expression of miR-551b predicts poor prognosis and promotes tumorigenesis by targeting PTP4A3 in human colorectal cancerEUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (13) : 5741 - 5751Sun, H-YQu, Z-CLiu, D-MZhang, W.Liu, G.Zhu, L.
- [22] Profiling potent, novel protein tyrosine phosphatase 4A3 small molecule inhibitors for ovarian cancer.CLINICAL CANCER RESEARCH, 2016, 22Sharlow, Elizabeth R.Salamoun, Joseph M.McQueeney, Kelley E.Lewandowski, SophieBryant, JenniferCheung, AlexPekic, PaulaLanden, Charles N., Jr.Wipf, PeterLazo, John S.
- [23] Targeting the TIE2 pathway with a novel small molecule vascular endothelial protein tyrosine phosphatase (VE-PTP) inhibitor in high-grade serous ovarian cancerGYNECOLOGIC ONCOLOGY, 2018, 149 : 14 - 14Cobb, L. P.Rickard, A.Herbert, J.Hanna, G.Palmer, G.Siamakpour-Reihani, S.Huang, Z.Peters, K.Kontos, C.Berchuck, A.Secord, A. A.
- [24] A Protein Tyrosine Phosphatase 4A3 (PTP4A3) inhibitor prevents and repairs pulmonary endothelial barrier dysfunction and ameliorates acute lung injury provoked by the SARS-CoV-2 Spike protein subunit 1 in k18-hACE2 transgenic miceFASEB JOURNAL, 2022, 36Biancatelli, Ruben Manuel Luciano ColungaSolopov, PavelDimitropoulou, ChristianaLazo, JohnSharlow, ElizabethCatravas, John
- [25] 4-(3-Phenyl-4-(3,4,5-trimethoxybenzoyl)-1H-pyrrol-1-yl)benzenesulfonamide, a Novel Carbonic Anhydrase and Wnt/β-Catenin Signaling Pathway Dual-Targeting Inhibitor with Potent Activity against Multidrug Resistant Cancer CellsJOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (21) : 14824 - 14842Masci, DomizianaPuxeddu, MichelaDi Magno, LauraD'Ambrosio, MicheleParisi, AnastasiaNalli, MariannaBai, RuoliColuccia, AntonioScio, PietroOrlando, VivianaD'Angelo, SaraBiagioni, StefanoUrbani, AndreaHamel, ErnestNocentini, AlessioFiliberti, SerenaTurati, MartaRonca, RobertoKopecka, JoannaRiganti, ChiaraFionda, CinziaBordone, RosaDella Rocca, GiorgiaCanettieri, GianlucaSupuran, Claudiu T.Silvestri, RomanoLa Regina, Giuseppe